Hemolysis inhibits humoral B-cell responses and modulates alloimmunization risk in patients with sickle cell disease. Pal M, Bao W, Wang R, Liu Y, et al. Blood 2021;137:269-280.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pal M, Bao W, Wang R, Liu Y, et al. Hemolysis inhibits humoral B-cell responses and modulates alloimmunization risk in patients with sickle cell disease. Blood 2021;137:269-280.
PMID: 33152749